Key result
Scn1b gene products β1 and β1B emerge as promising antiarrhythmic targets regulating cardiac conduction.
Why the study?
Recent evidence suggests cardiac voltage-gated sodium channel Scn1b products have novel roles in action potential conduction and intracellular signaling, raising questions about their function and therapeutic potential.
Design
Review
Authors
Loading...
Should not change antiarrhythmic practice; leaves open β1/β1B as targets for future therapeutics pending validation.
This review highlights the emerging roles of cardiac voltage-gated sodium channel β1 and β1B subunits in intracellular signaling and action potential conduction, identifying them as potential novel targets for antiarrhythmic therapies.
Williams et al. (2024) conducted a review in Arrhythmias. Voltage-gated sodium channel β1 and β1B targeting was evaluated. The Scn1b gene products β1 and β1B have novel roles in cardiac action potential conduction and intracellular signaling, making them attractive targets for novel antiarrhythmic therapeutics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: